Cybin (HELP) Exchange Rate Effect (2020 - 2026)
Cybin's (HELP) quarterly Exchange Rate Effect came in at -$87000.0 in Q1 2026, down 140.07% YoY from $217128.2 in Q1 2025, and down 107.14% on a QoQ basis from -$42000.0 in Q4 2025.
Cybin (HELP) Exchange Rate Effect (2020 - 2026) Analysis & Trends
Cybin (HELP) has 7 years of Exchange Rate Effect data on file, last reported at -$87000.0 in Q1 2026.
- Quarterly Exchange Rate Effect fell 140.07% year-over-year to -$87000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$269000.0 (up 64.1% YoY) and the FY2026 annual result came in at -$269000.0, up 60.84% from the prior year.
- Exchange Rate Effect declined to -$87000.0 in Q1 2026, from -$42000.0 in the prior quarter.
- In the past five years, Exchange Rate Effect ranged from a high of $145681.8 in Q3 2022 to a low of -$1.9 million in Q2 2022.
- A 5-year average of -$185072.8 and a median of -$42000.0 in 2025 frame the typical range for Exchange Rate Effect.
- Annual changes were most pronounced in 2022 — Exchange Rate Effect surged 6012.79% — and 2023, when it tumbled 399.12%.
- Tracing HELP's Exchange Rate Effect over 5 years: stood at $68513.4 in 2022, then tumbled by 399.12% to -$204935.4 in 2023, then sank by 223.03% to -$662000.0 in 2024, then soared by 93.66% to -$42000.0 in 2025, then slumped by 107.14% to -$87000.0 in 2026.
- The last three Exchange Rate Effect figures came in at -$87000.0 (Q1 2026), -$42000.0 (Q4 2025), and -$46000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -3.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -300,000.00 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 19.84 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -14,590.12 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -2.45 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -287,000.00 |
| 10 | Cybin | 417.29 Mn | 417.29 Mn | - | -87,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -87,000.00 |
| Mar 31, 2026 | -87,000.00 |
| Dec 31, 2025 | -42,000.00 |
| Dec 31, 2025 | -42,000.00 |
| Sep 30, 2025 | -46,000.00 |
| Sep 30, 2025 | -46,000.00 |
| Jun 30, 2025 | -94,000.00 |
| Jun 30, 2025 | -94,000.00 |
| Mar 31, 2025 | -36,239.66 |
| Mar 31, 2025 | -36,239.66 |
| Dec 31, 2024 | -662,000.00 |
| Dec 31, 2024 | -662,000.00 |
| Sep 30, 2024 | 50,000.00 |
| Sep 30, 2024 | 50,000.00 |
| Jun 30, 2024 | -101,000.00 |
| Jun 30, 2024 | -101,000.00 |
| Mar 31, 2024 | 40,074.11 |
| Mar 31, 2024 | 40,074.11 |
| Dec 31, 2023 | -204,935.41 |
| Dec 31, 2023 | -204,935.41 |